MXPA04007071A - Tibolona en el tratamiento de problemas asociados con la administracion de medicamentos que dictan la sintesis de estrogenos endogenos. - Google Patents

Tibolona en el tratamiento de problemas asociados con la administracion de medicamentos que dictan la sintesis de estrogenos endogenos.

Info

Publication number
MXPA04007071A
MXPA04007071A MXPA04007071A MXPA04007071A MXPA04007071A MX PA04007071 A MXPA04007071 A MX PA04007071A MX PA04007071 A MXPA04007071 A MX PA04007071A MX PA04007071 A MXPA04007071 A MX PA04007071A MX PA04007071 A MXPA04007071 A MX PA04007071A
Authority
MX
Mexico
Prior art keywords
estrogen
treatment
synthesis
tibolone
prevents
Prior art date
Application number
MXPA04007071A
Other languages
English (en)
Spanish (es)
Inventor
Bundred Nigel
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of MXPA04007071A publication Critical patent/MXPA04007071A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
MXPA04007071A 2002-01-22 2003-01-16 Tibolona en el tratamiento de problemas asociados con la administracion de medicamentos que dictan la sintesis de estrogenos endogenos. MXPA04007071A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02075235 2002-01-22
PCT/EP2003/000373 WO2003061665A1 (en) 2002-01-22 2003-01-16 Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen

Publications (1)

Publication Number Publication Date
MXPA04007071A true MXPA04007071A (es) 2004-10-29

Family

ID=27589110

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04007071A MXPA04007071A (es) 2002-01-22 2003-01-16 Tibolona en el tratamiento de problemas asociados con la administracion de medicamentos que dictan la sintesis de estrogenos endogenos.

Country Status (16)

Country Link
US (1) US20050124592A1 (enExample)
EP (1) EP1469861A1 (enExample)
JP (1) JP2005518412A (enExample)
KR (1) KR20040073572A (enExample)
CN (1) CN1620298A (enExample)
BR (1) BR0306789A (enExample)
CA (1) CA2472240A1 (enExample)
EC (1) ECSP045179A (enExample)
HR (1) HRP20040635A2 (enExample)
IL (1) IL162769A0 (enExample)
IS (1) IS7338A (enExample)
MX (1) MXPA04007071A (enExample)
PL (1) PL371181A1 (enExample)
RU (1) RU2004125594A (enExample)
WO (1) WO2003061665A1 (enExample)
ZA (1) ZA200405262B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0302572D0 (en) 2003-02-05 2003-03-12 Astrazeneca Ab Method of treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
AU671706B2 (en) * 1993-03-05 1996-09-05 Akzo N.V. Use of a Pregnane Derivative
JP2002522425A (ja) * 1998-08-07 2002-07-23 カイロン コーポレイション エストロゲンレセプターモジュレーターとしての置換イソオキサゾール

Also Published As

Publication number Publication date
JP2005518412A (ja) 2005-06-23
RU2004125594A (ru) 2005-03-10
IS7338A (is) 2004-06-28
IL162769A0 (en) 2005-11-20
CN1620298A (zh) 2005-05-25
WO2003061665A1 (en) 2003-07-31
EP1469861A1 (en) 2004-10-27
US20050124592A1 (en) 2005-06-09
BR0306789A (pt) 2004-12-28
CA2472240A1 (en) 2003-07-31
ECSP045179A (es) 2004-08-27
ZA200405262B (en) 2005-08-31
PL371181A1 (en) 2005-06-13
KR20040073572A (ko) 2004-08-19
HRP20040635A2 (en) 2004-10-31

Similar Documents

Publication Publication Date Title
US6500814B1 (en) Hormonal contraceptive
RU2005140938A (ru) Дроспиренон для гормональной заместительной терапии
HU214598B (hu) Eljárás fogamzásgátló és hormonterápiához alkalmazható, ösztrogént és progesztint tartalmazó gyógyszerkészítmények előállítására
US20110009373A1 (en) Composition comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis
US20050222100A1 (en) Treatment of post-menopausal complaints in breast cancer patients comprising tibolone and a serm
SK11902002A3 (sk) Použitie exemestanu na prípravu liečiva
MXPA04007071A (es) Tibolona en el tratamiento de problemas asociados con la administracion de medicamentos que dictan la sintesis de estrogenos endogenos.
CA2248841C (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
CA2100086C (en) Compositions and methods for alleviating menopausal symptoms
AU2003236806A1 (en) Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen
HK1113546A (en) Composition comprising a combination of an aromatase inhibitor, a progestin and an estrogen, and its use for the treatment of endometriosis
HK1082918B (en) Use of a combination of an aromatase inhibitor, a progestin and an oestrogen for the treatment of endometriosis

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: N.V. ORGANON.*

FA Abandonment or withdrawal